🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
To determine what side effects and what clinical effect, if any, the admini...
Status
Completed
Location
Research site
Start Date
2002-11
Trial ID
NCT00048555
Treatments Being Tested
The purpose of this clinical trial is to evaluate efficacy and safety of ti...
Status
Recruiting
Location
Mayo Clinic Cancer Center
Start Date
2026-06-12
Trial ID
NCT07104032
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
Idiopathic inflammatory myopathies (IIM) are a group of autoimmune conditio...
Status
Recruiting
Location
Singapore General Hospital
Start Date
2024-12-26
Trial ID
NCT07775235
Treatments Being Tested
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Status
Completed
Location
University Hospital
Start Date
2002-04
Trial ID
NCT00965289
Treatments Being Tested
This is an open label clinical study: Phase Ia is a dose escalation phase, ...
Status
Recruiting
Location
The First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-07-01
Trial ID
NCT07073833
Treatments Being Tested
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
RATIONALE: Monoclonal antibodies, such as epratuzumab and rituximab, can bl...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-01
Trial ID
NCT00301821
Treatments Being Tested